Reply to: Frequent self-assessments in ALS clinical trials: Worthwhile or an unnecessary burden?

Ann Clin Transl Neurol. 2020 Oct;7(10):2076-2077. doi: 10.1002/acn3.51177. Epub 2020 Sep 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amyotrophic Lateral Sclerosis* / therapy
  • Humans
  • Proof of Concept Study
  • Self-Assessment*

Supplementary concepts

  • Amyotrophic Lateral Sclerosis 2, Juvenile